Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Ran Chen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ran Chen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Beyond Approval: Mastering Medical Device Post-Market Surveillance in the UAE with Pure Global's Expert Insights

4:02
 
Share
 

Manage episode 505866472 series 3684506
Content provided by Ran Chen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ran Chen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
The United Arab Emirates is a fast-growing and attractive market for MedTech innovators. However, gaining market access is only the first step. Staying in the market requires a deep understanding of the UAE's stringent and actively enforced post-market surveillance (PMS) regulations. This episode provides a detailed overview of the key PMS requirements set by the Ministry of Health and Prevention (MOHAP). We explore the essential components of a compliant PMS system, including the vigilance process, strict adverse event reporting timelines, and the implementation of Field Safety Corrective Actions. Learn why appointing a knowledgeable local representative is not just a regulatory formality but a critical component of your risk management strategy, ensuring you can respond to incidents swiftly and effectively to maintain your market presence. Case Study Highlight: Imagine your newly launched diagnostic device begins showing a pattern of minor malfunctions in the UAE's unique climate. Are you prepared to navigate MOHAP's 10-day reporting window for incidents that could potentially become serious? A failure to act correctly could escalate a manageable issue into a full product recall, jeopardizing your investment and market reputation. Key Takeaways From This Episode: 1. What are the core pillars of an effective PMS system for the UAE market? 2. How does the UAE's definition of a "reportable incident" differ from EU or US standards? 3. Why is appointing a local authorized representative more than just a regulatory checkbox? 4. What are the specific timelines for reporting different classes of adverse events to MOHAP? 5. What are the potential consequences of failing to meet UAE vigilance reporting deadlines? 6. What is a Field Safety Corrective Action, and when must it be initiated in the UAE? 7. How can you leverage post-market data from the UAE for global product improvement? 8. What key documentation must be maintained for a PMS audit by UAE authorities? Contact us for more information at [email protected] or visit https://pureglobal.com/.
  continue reading

28 episodes

Artwork
iconShare
 
Manage episode 505866472 series 3684506
Content provided by Ran Chen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ran Chen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
The United Arab Emirates is a fast-growing and attractive market for MedTech innovators. However, gaining market access is only the first step. Staying in the market requires a deep understanding of the UAE's stringent and actively enforced post-market surveillance (PMS) regulations. This episode provides a detailed overview of the key PMS requirements set by the Ministry of Health and Prevention (MOHAP). We explore the essential components of a compliant PMS system, including the vigilance process, strict adverse event reporting timelines, and the implementation of Field Safety Corrective Actions. Learn why appointing a knowledgeable local representative is not just a regulatory formality but a critical component of your risk management strategy, ensuring you can respond to incidents swiftly and effectively to maintain your market presence. Case Study Highlight: Imagine your newly launched diagnostic device begins showing a pattern of minor malfunctions in the UAE's unique climate. Are you prepared to navigate MOHAP's 10-day reporting window for incidents that could potentially become serious? A failure to act correctly could escalate a manageable issue into a full product recall, jeopardizing your investment and market reputation. Key Takeaways From This Episode: 1. What are the core pillars of an effective PMS system for the UAE market? 2. How does the UAE's definition of a "reportable incident" differ from EU or US standards? 3. Why is appointing a local authorized representative more than just a regulatory checkbox? 4. What are the specific timelines for reporting different classes of adverse events to MOHAP? 5. What are the potential consequences of failing to meet UAE vigilance reporting deadlines? 6. What is a Field Safety Corrective Action, and when must it be initiated in the UAE? 7. How can you leverage post-market data from the UAE for global product improvement? 8. What key documentation must be maintained for a PMS audit by UAE authorities? Contact us for more information at [email protected] or visit https://pureglobal.com/.
  continue reading

28 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play